Telomir Pharmaceuticals, Inc. (TELO)

Every official Telomir Pharmaceuticals, Inc. filing in one place: annual reports, quarterly results, current reports, proxy statements, shareholding and announcements, straight from the regulator. Free to search.

Telomir Pharmaceuticals, Inc. documents

• Telomir Pharmaceuticals, Inc. 10-K 2026TELO 10-K 2026: annual report for fiscal 2026
• Telomir Pharmaceuticals, Inc. 10-K 2025TELO 10-K 2025: annual report for fiscal 2025
• Telomir Pharmaceuticals, Inc. 10-K 2024TELO 10-K 2024: annual report for fiscal 2024
• Telomir Pharmaceuticals, Inc. 10-K 2023TELO 10-K 2023: annual report for fiscal 2023
• Telomir Pharmaceuticals, Inc. 10-K 2022TELO 10-K 2022: annual report for fiscal 2022
• Telomir Pharmaceuticals, Inc. 10-Q 2026TELO 10-Q 2026: quarterly report for fiscal 2026
• Telomir Pharmaceuticals, Inc. 10-Q 2025TELO 10-Q 2025: quarterly report for fiscal 2025
• Telomir Pharmaceuticals, Inc. 10-Q 2024TELO 10-Q 2024: quarterly report for fiscal 2024
• Telomir Pharmaceuticals, Inc. 10-Q 2023TELO 10-Q 2023: quarterly report for fiscal 2023
• Telomir Pharmaceuticals, Inc. 10-Q 2022TELO 10-Q 2022: quarterly report for fiscal 2022
• Telomir Pharmaceuticals, Inc. 8-K 2026TELO 8-K 2026: current report for fiscal 2026
• Telomir Pharmaceuticals, Inc. 8-K 2025TELO 8-K 2025: current report for fiscal 2025
• Telomir Pharmaceuticals, Inc. 8-K 2024TELO 8-K 2024: current report for fiscal 2024
• Telomir Pharmaceuticals, Inc. 8-K 2023TELO 8-K 2023: current report for fiscal 2023
• Telomir Pharmaceuticals, Inc. 8-K 2022TELO 8-K 2022: current report for fiscal 2022
• Telomir Pharmaceuticals, Inc. DEF 14A 2026TELO DEF 14A 2026: proxy statement for fiscal 2026
• Telomir Pharmaceuticals, Inc. DEF 14A 2025TELO DEF 14A 2025: proxy statement for fiscal 2025
• Telomir Pharmaceuticals, Inc. DEF 14A 2024TELO DEF 14A 2024: proxy statement for fiscal 2024
• Telomir Pharmaceuticals, Inc. DEF 14A 2023TELO DEF 14A 2023: proxy statement for fiscal 2023
• Telomir Pharmaceuticals, Inc. DEF 14A 2022TELO DEF 14A 2022: proxy statement for fiscal 2022
• Telomir Pharmaceuticals, Inc. Form 4 2026TELO Form 4 2026: insider trading filing for fiscal 2026
• Telomir Pharmaceuticals, Inc. Form 4 2025TELO Form 4 2025: insider trading filing for fiscal 2025
• Telomir Pharmaceuticals, Inc. Form 4 2024TELO Form 4 2024: insider trading filing for fiscal 2024
• Telomir Pharmaceuticals, Inc. Form 4 2023TELO Form 4 2023: insider trading filing for fiscal 2023
• Telomir Pharmaceuticals, Inc. Form 4 2022TELO Form 4 2022: insider trading filing for fiscal 2022
• Telomir Pharmaceuticals, Inc. S-1 2026TELO S-1 2026: registration statement for fiscal 2026
• Telomir Pharmaceuticals, Inc. S-1 2025TELO S-1 2025: registration statement for fiscal 2025
• Telomir Pharmaceuticals, Inc. S-1 2024TELO S-1 2024: registration statement for fiscal 2024
• Telomir Pharmaceuticals, Inc. S-1 2023TELO S-1 2023: registration statement for fiscal 2023
• Telomir Pharmaceuticals, Inc. S-1 2022TELO S-1 2022: registration statement for fiscal 2022
• Telomir Pharmaceuticals, Inc. 13F 2026TELO 13F 2026: institutional holdings for fiscal 2026
• Telomir Pharmaceuticals, Inc. 13F 2025TELO 13F 2025: institutional holdings for fiscal 2025
• Telomir Pharmaceuticals, Inc. 13F 2024TELO 13F 2024: institutional holdings for fiscal 2024
• Telomir Pharmaceuticals, Inc. 13F 2023TELO 13F 2023: institutional holdings for fiscal 2023
• Telomir Pharmaceuticals, Inc. 13F 2022TELO 13F 2022: institutional holdings for fiscal 2022

More companies